Company Portfolio
| Country | Product | INN | Pharma Dosage Form | Strengths | Marketing Status | Approval Date Official Letter |
|---|---|---|---|---|---|---|
| MÉXICO | RAAZID | Telmisartan + HCTZ | TABLET | 80 mg+12.5 mg 80 mg+25.0 mg | NA | 2025-06-19 |
| MÉXICO | SENSIBIT | Loratadine | TABLET | 10 mg | NA | 2025-01-09 |
| MÉXICO | SENSIBIT | Loratadine | TABLET | 10 mg | NA | 2025-05-15 |
| BRASIL | SENSIBIT D NF | Phenylephrine + Loratadine + Paracetamol | TABLET | 2.5 mg+5 mg+500 mg | YES | 2022-06-17 |
| MÉXICO | SENSIBIT D NF | Phenylephrine + Loratadine + Paracetamol | TABLET | 2.5 mg+5 mg+500 mg | NA | 2025-07-17 |
| MÉXICO | SIIRRITAB | Trimebutine + Simeticone | TABLET | 100 mg+37.5 mg 200 mg+75 mg | NA | 2025-12-04 |
| MÉXICO | THOREVA | Atorvastatine | TABLET | 10 mg 20 mg 40 mg 80 mg | NA | 2025-11-27 |
| MÉXICO | TRONIUM IV | Esomeprazol | SOLUTION | 40 mg/5 mL | NA | 2025-07-09 |
| MÉXICO | TRONIUM IV | Esomeprazol | SOLUTION | 40 mg/5 mL | NA | 2025-12-05 |
| MÉXICO | UNILOID | Hydrocortisone | CREAM | 0.1 % | NA | 2025-11-14 |
| MÉXICO | ANALGEN NF | Naproxen + Lidocaine | GEL | 10 g+5 g | NA | 2025-09-09 |
| MÉXICO | CICLOFERON | Aciclovir | SOLUTION | NA | NA | 2025-07-20 |
| MÉXICO | CICLOFERON | Aciclovir | SOLUTION (SPRAY) | 5 g/100 mL | NA | 2025-08-03 |
| MÉXICO | FOSFONAT | Ibandronic acid | TABLET | NA | NA | 2025-07-06 |
| MÉXICO | GLIPAMET | NA | NA | 2025-11-10 | ||
| MÉXICO | GLIPA-MT | Sitagliptin + Metformin | TABLET | NA | NA | 2025-08-25 |
| MÉXICO | GLITACAR-1 | Pioglitazone | TABLET | 15 mg 30 mg | NA | 2023-10-30 |
| MÉXICO | L-OMBRIX-DUET | Mebendazole + Quinfamide | TABLET | NA | NA | 2025-12-12 |
| MÉXICO | MICRORGAN | Ciprofloxacin | TABLET | 500 mg | NA | 2026-01-20 |
| MÉXICO | MINOFEN | TABLET | NA | NA | 2016-03-04 | |
| MÉXICO | PRAZOLAN | Pantoprazol | SOLUTION | 40 mg | NA | 2025-06-05 |
| MÉXICO | QUADRILOID | CREAM | NA | NA | 2024-10-03 | |
| MÉXICO | RAAZID | Telmisartan+HCTZ | TABLET | NA | NA | 2025-09-08 |
| MÉXICO | SOTAVENT | TABLET | NA | NA | 2025-01-20 | |
| MÉXICO | VIATOR-A | TABLET | NA | NA | 2025-11-04 | |
| MÉXICO | FACIDEX | Famotidine | TABLET | 10 mg | NA | 2025-08-22 |
| MÉXICO | FLAGENASE | Metronidazole | ovule | 500 mg | NA | 2024-08-09 |
| MÉXICO | FLAGENASE | Metronidazole | TABLET | 250 mg 500 mg | NA | 2025-05-21 |
| MÉXICO | FLAGENASE 400 PEDIATRICO | Metronidazole + Diiodohydroxyquinoleine | SUSPENSION | 2.5 g+2 g/100 mL | NA | 2026-01-16 |
| MÉXICO | GLITACAR-1 | Pioglitazone | TABLET | 15 mg 30 mg | NA | 2025-05-30 |
| MÉXICO | INHIBITRON F | Omeprazole | CAPSULE | 40 mg | NA | 2025-11-07 |
| MÉXICO | INHIBITRON F | Omeprazole | CAPSULE | 40 mg | NA | 2025-10-29 |
| COLOMBIA | L-OMBRIX-DUET | Mebendazole + Quinfamide | SUSPENSION | 60 mg+10 mg/mL 60 mg+20 mg/mL | YES | 2025-11-12 |
| MÉXICO | L-OMBRIX-DUET | Mebendazole + Quinfamide | SUSPENSION | 1) 60 mg+10 mg/mL 2) 60 mg+20 mg/mL | NA | 2025-11-12 |
| MÉXICO | MUCOVIBROL | Ambroxol | SOLUTION | 0.300 g/100 mL 0.750 g/100 mL | NA | 2025-05-07 |
| MÉXICO | MYCELVAN | Terbinafine | TABLET | 250 mg | NA | 2026-01-08 |
| MÉXICO | PROSIQUE | Fluoxetine | CAPSULE | 20 mg | NA | 2025-10-24 |
| MÉXICO | QUIMARA-1 | Imiquimod | CREAM | 50 mg/g | NA | 2025-07-17 |
| MÉXICO | QUIMARA-1 | Imiquimod | CREAM | 50 mg/g | NA | 2025-12-19 |
| MÉXICO | RAAS | Telmisartan | TABLET | 40 mg 80 mg | NA | 2025-01-20 |
| MÉXICO | ANALGEN | Naproxen | TABLET | 550 mg+220 mg | NA | 2025-12-19 |
| MÉXICO | CANDIFLUX | Fluconazole | CAPSULE | 150 mg | NA | 2025-11-28 |
| MÉXICO | CO-DEGREGAN | Clopidogrel bisulfate + Acetylsalicylic acid | TABLET | 75 mg+100 mg | NA | 2025-10-28 |
| COLOMBIA | CONTINENTAL | Solifenacine | TABLET | 5 mg 10 mg | YES | 2024-06-12 |
| MÉXICO | CONTINENTAL | Solifenacine | TABLET | 5 mg 10 mg | NA | 2024-06-12 |
| MÉXICO | CONTINENTAL | Solifenacine | TABLET | 5 mg 10 mg | NA | 2022-07-27 |
| BRASIL | DAFLOXEN | Naproxen sodium | TABLET | 275 mg 550 mg | YES | 2024-06-28 |
| MÉXICO | DAPOSAR | Dapagliflozine | TABLET | 10 mg | NA | 2025-03-21 |
| MÉXICO | DOSCOXEL | Etoricoxib | TABLET | 60 mg 90 mg 120 mg | NA | 2025-10-22 |
| MÉXICO | DOSCOXEL | Etoricoxib | TABLET | 60 mg 90 mg 120 mg | NA | 2025-10-22 |
| MÉXICO | DOSCOXEL | Etoricoxib | TABLET | 60 mg 90 mg 120 mg | NA | 2025-10-22 |
| MÉXICO | EVEREST | Montelukast | TABLET | 10 mg | YES | 2021-12-15 |
| MÉXICO | EVEREST | Montelukast | TABLET | 10 mg | NA | 2023-10-12 |
| MÉXICO | EVEREST | Montelukast | TABLET | 10 mg | NA | 2021-12-15 |
| Country | #Rows |
|---|---|
| MÉXICO | 50 |
| BRASIL | 2 |
| COLOMBIA | 2 |